“…In 2005, Stadler et al obtained nine agaric acid glycerides from A. macrosporus mycelium, namely agaricoglyceride A, agaricoglyceride B, agaricoglyceride C, agaricoglyceride D, (3,5dichloro-4-methoxyphenyl)methanol, 3,5-dichloro-4-anisic acid, agaric ester, monoacetyl-agaricoglycerides A (separated into inseparable mixtures), and all compounds had a positive effect on neurolysin and angiotensin-converting enzyme, with IC 50 = 0.2 μmol/L for agaricoglyceride A and 0.05 μmol/L for monoacetyl-agaricoglycerides in the anti-neurolysin [26].In 2008, Barros et al used normal-phase high performance liquid chromatography (HPLC) to determine the content of tocopherol in the ascospores of A. arvensis, A. bisporus, A. romagnesii, A. silvaticus and A. silvicola, and the results showed that all five species of fungi contained α-tocopherol, and except A. romagnesii, four fungi contained β-tocopherol [27].In 2011, Ueguchi et al identified two phenylhexane derivatives from A. blazei substrates, 1-[4-(Hydroxymethyl)phenyl]hexan-1-ol and 4-hydroxymethyl-1-phenyl-n-hexan-1-one, both of them showed moderate cytotoxicity against HepG2 cells with IC 50 39.2 ± 5.68 μmol/L and 28.9 ± 2.06 μmol/L, respectively [11]. In 2013, Dong et al obtained brefeldin A, an active component of Erk1/2 with oestrogenic activity from A. blazei mycelium [28].In 2016, Hammann et al identified an ester, drimenol linoleic acid ester, from A. blazei substrates using GCMS [29].In 2018, Waqas identified seven compounds from A. blazei substrates by GCMS, such as 1,2-benzenedicarboxylic acid, mono (2-ethylhexyl) ester et al and 1,2-benzenedicarboxylic acid, mono (2-ethylhexyl) ester inhibited Streptomyces intermedius and Fusarium spinosum by 44% and 50% [23].In 2020, Wu et al obtained fourteen other types of compounds from A. gennadii, such as macrosphelide A, 7-acetyl-4-methyl-1-azulenecarboxylic acid et al [13].…”